Differences between Radiopharmaceuticals and General Pharmaceuticals

Characteristic half-life

Radioisotope is essential to drug efficacy while the ligand acts as a carrier to the disease region

Strong impact of market preoccupation occurred from the imaging market features

Small market size compared to general pharmaceuticals but low development cost from the imaging market features

The market leader invariably dominates the region

Manufacturing technology plays a pivotal role in the development of new drugs